These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10175979)

  • 1. Measuring patient benefit from botulinum toxin in the treatment of dystonia. Feasibility of cost-utility analysis.
    Gudex CM; Hawthorne MR; Butler AG; Duffey PO
    Pharmacoeconomics; 1997 Dec; 12(6):675-84. PubMed ID: 10175979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dystonia and botulinum toxin treatment on health-related quality of life.
    Gudex CM; Hawthorne MR; Butler AG; Duffey P
    Mov Disord; 1998 Nov; 13(6):941-6. PubMed ID: 9827619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin for treatment of dystonia.
    Dressler D
    Eur J Neurol; 2010 Jul; 17 Suppl 1():88-96. PubMed ID: 20590814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jaw-opening dystonia: Quality of life after botulinum toxin injections.
    Charous SJ; Comella CL; Fan W
    Ear Nose Throat J; 2011 Feb; 90(2):E9. PubMed ID: 21328222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of treating dystonias and hemifacial spasm with botulinum toxin A.
    Dodel RC; Kirchner A; Koehne-Volland R; Künig G; Ceballos-Baumann A; Naumann M; Brashear A; Richter HP; Szucs TD; Oertel WH
    Pharmacoeconomics; 1997 Dec; 12(6):695-706. PubMed ID: 10175981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value.
    Zoons E; Dijkgraaf MG; Dijk JM; van Schaik IN; Tijssen MA
    J Neurol; 2012 Dec; 259(12):2519-26. PubMed ID: 22552527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative EMG in botulinum toxin treatment of cervical dystonia. A double-blind, placebo-controlled study.
    Ostergaard L; Fuglsang-Frederiksen A; Werdelin L; Sjö O; Winkel H
    Electroencephalogr Clin Neurophysiol; 1994 Dec; 93(6):434-9. PubMed ID: 7529693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study.
    Drexel SC; Klietz M; Kollewe K; Paracka L; Kutschenko A; Kopp B; Lange F; Wegner F; Dressler D
    J Neural Transm (Vienna); 2020 Jan; 127(1):61-70. PubMed ID: 31802240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative electromyographical changes in cervical dystonia after treatment with botulinum toxin.
    Fuglsang-Frederiksen A; Ostergaard L; Sjö O; Werdelin L; Winkel H
    Electromyogr Clin Neurophysiol; 1998 Mar; 38(2):75-9. PubMed ID: 9553744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurology.
    Giladi N; Meer J; Kidan C; Greenberg E; Gross B; Honigman S
    Isr J Med Sci; 1994 Nov; 30(11):816-9. PubMed ID: 7982770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of oromandibular dystonia with botulinum toxin.
    Hermanowicz N; Truong DD
    Laryngoscope; 1991 Nov; 101(11):1216-8. PubMed ID: 1943423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local treatment of dystonia and spasticity with injections of botulinum-A toxin.
    Calne S
    Axone; 1993 Jun; 14(4):85-8. PubMed ID: 8274387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of laryngeal dystonia with botulinum toxin].
    Olthoff A; Grosheva M; Reichel G; Volk GF; Laskawi R
    Fortschr Neurol Psychiatr; 2017 Aug; 85(8):450-462. PubMed ID: 28841743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of botulinum toxin injections for spasmodic torticollis of tardive dystonia.
    Kaufman DM
    J Neuropsychiatry Clin Neurosci; 1994; 6(1):50-3. PubMed ID: 8148637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service.
    Whitaker J; Butler A; Semlyen JK; Barnes MP
    Arch Phys Med Rehabil; 2001 Apr; 82(4):480-4. PubMed ID: 11295008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum toxin in the treatment of focal dystonias: own experience with botulinum toxin].
    Stefanoff P; Kiliszek M; Friedman A
    Neurol Neurochir Pol; 2000; 34(1):61-70. PubMed ID: 10849905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type B de novo therapy of cervical dystonia: frequency of antibody induced therapy failure.
    Dressler D; Bigalke H
    J Neurol; 2005 Aug; 252(8):904-7. PubMed ID: 15761672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis.
    Dressler D; Benecke R
    Eur Neurol; 2003; 49(1):34-8. PubMed ID: 12464716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.